Clinical Trials
2 trialsNCT03654105 2026-03-27
SMILE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Active not recruiting
NCT04184921 2026-02-03
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Completed